After months of terrible headlines and some massive layoffs, Theranos is making a big push to turn around its reputation. The blood-testing startup is appointing an advisory board of pharmaceutical and medical device experts to work alongside its scientific advisors, reports Fast Company‘s Christina Farr. The board will be co-led by prominent academic Dr. Channing Robertson and Howie Rosen, the CEO of AcelRx Pharmaceuticals Inc., a specialty pharma company.MB
collectionsInnovation FestivalCurrent Issue
World Changing Ideas
New workplaces, new food sources, new medicine--even an entirely new economic system.
The major tech ecosystems that battle for our attention and dollars.
What’s next for hardware, software, and services.
The brave new world of automation, from AI to drones.
How our urban centers are building toward the future.
Most Creative People
See members of our Most Creative People in Business community: leaders who are shaping the future of business in creative ways.
An award-winning team of journalists, designers, and videographers who tell brand stories through Fast Company's distinctive lens.